Overview Dividends

(ALAB) Astera Labs, Common Stock - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US04626A1034

Connectivity Platform, Retimers, Controllers, Switches

EPS (Earnings per Share)

EPS Growth (3y CAGR): 123.44%
EPS Trend (3y Corr): 86.0%

Last SUE: 1.68σ
Qual. Beats: 2

Revenue

Revenue Growth (3y CAGR): 141.73%
Revenue Trend (3y Corr): 95.4%

Last SUE: 3.54σ
Qual. Beats: 3

Risk via 10d forecast
Volatility	95.9%
Value at Risk 5%th	130%
Relative Tail Risk	-17.41%

Reward TTM
Sharpe Ratio	0.83
Alpha	30.62

Character TTM
Hurst Exponent	0.539
Beta	2.384
Beta Downside	2.200

Drawdowns 3y
Max DD	63.69%
Mean DD	27.92%
Median DD	30.34%

Description: ALAB Astera Labs, Common Stock September 29, 2025

Astera Labs, Inc. (NASDAQ: ALAB) is a California-based fabless semiconductor firm that builds and sells connectivity solutions aimed at cloud-scale and AI data-center infrastructure. Founded in 2017, the company targets hyperscalers and system OEMs with a portfolio that combines hardware and software to manage high-speed interconnects.

The core offering is an “intelligent connectivity platform” that fuses mixed-signal ASICs-featuring embedded microcontrollers, sensors, and retimers-with the COSMOS software suite. COSMOS provides link-level diagnostics, fleet-wide resource orchestration, and reliability-aware (RAS) management, enabling operators to monitor and optimize thousands of ports in real time.

Product lines include PCIe 5.0/CXL smart DSP retimers, Ethernet smart cable modules, CXL memory-connectivity controllers, and programmable fabric switches. These components are positioned to address the rapid migration to PCIe 5.0 and CXL standards, which analysts estimate will drive $12-$15 billion of incremental spend in the data-center interconnect market through 2028.

Recent financial disclosures show a year-over-year revenue growth of ~68 % in Q2 2024, with gross margins expanding to 55 % as the firm scales volume and shifts to higher-margin software licensing. The broader semiconductor connectivity segment is benefiting from a 10-12 % CAGR in AI-driven workloads, while supply-chain tightening on advanced silicon continues to create entry barriers for new competitors.

If you want a data-driven, quantitative assessment of ALAB’s valuation relative to its peers, a deeper dive on ValueRay’s platform can provide the metrics and scenario analysis you need.

ALAB Stock Overview

Market Cap in USD	23,527m
Sub-Industry	Semiconductors
IPO / Inception	2024-03-20
Return 12m vs S&P 500	27.8%
Analyst Rating	4.47 of 5

ALAB Dividends

Currently no dividends paid

ALAB Growth Ratios

Metric	Value
CAGR 3y	123.06%
CAGR/Max DD Calmar Ratio	1.93
CAGR/Mean DD Pain Ratio	4.41
Current Volume	10309.3k
Average Volume	5409.9k

Piotroski VR‑10 (Strict, 0-10) 5.0

Net Income (198.9m TTM) > 0 and > 6% of Revenue (6% = 43.4m TTM)

FCFTA 0.16 (>2.0%) and ΔFCFTA 7.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 164.5% (prev 280.5%; Δ -116.0pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.19 (>3.0%) and CFO 263.7m > Net Income 198.9m (YES >=105%, WARN >=100%)

Net Debt (-140.4m) to EBITDA (171.6m) ratio: -0.82 <= 3.0 (WARN <= 3.5)

Current Ratio 12.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (180.6m) change vs 12m ago 15.18% (target <= -2.0% for YES)

Gross Margin 75.41% (prev 77.62%; Δ -2.21pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 60.65% (prev 31.10%; Δ 29.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -5.23 (EBITDA TTM 171.6m / Interest Expense TTM -31.9m) >= 6 (WARN >= 3)

Altman Z'' 6.18

(A) 0.85 = (Total Current Assets 1.29b - Total Current Liabilities 101.0m) / Total Assets 1.40b

(B) -0.02 = Retained Earnings (Balance) -34.6m / Total Assets 1.40b

(D) -0.24 = Book Value of Equity -30.5m / Total Liabilities 129.5m

Total Rating: 6.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 72.37

1. Piotroski 5.0pt

2. FCF Yield 1.02%

3. FCF Margin 31.73%

4. Debt/Equity 0.00

5. Debt/Ebitda -0.82

6. ROIC - WACC (= -2.88)%

7. RoE 18.02%

8. Rev. Trend 95.44%

9. EPS Trend 85.98%

What is the price of ALAB shares?

As of November 21, 2025, the stock is trading at USD 139.29 with a total of 10,309,329 shares traded.
Over the past week, the price has changed by -3.59%, over one month by -10.89%, over three months by -19.23% and over the past year by +42.98%.

Is ALAB a buy, sell or hold?

Astera Labs, Common Stock has received a consensus analysts rating of 4.47. Therefore, it is recommended to buy ALAB.

Strong Buy: 9
Buy: 7
Hold: 1
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the ALAB price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	198.3	42.4%
Analysts Target Price	198.3	42.4%
ValueRay Target Price	147.1	5.6%

ALAB Fundamental Data Overview November 21, 2025

Market Cap USD = 23.53b (23.53b USD * 1.0 USD.USD)
P/E Trailing = 114.1721
P/E Forward = 60.6061
P/S = 32.5385
P/B = 18.8609
Beta = None
Revenue TTM = 723.0m USD
EBIT TTM = 166.6m USD
EBITDA TTM = 171.6m USD
Long Term Debt = 1.29m USD (from capitalLeaseObligations, last fiscal year)
Short Term Debt = 1.29m USD (from shortTermDebt, last fiscal year)
Debt = 1.29m USD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = -140.4m USD (from netDebt column, last quarter)
Enterprise Value = 22.39b USD (23.53b + Debt 1.29m - CCE 1.13b)
Interest Coverage Ratio = -5.23 (Ebit TTM 166.6m / Interest Expense TTM -31.9m)
FCF Yield = 1.02% (FCF TTM 229.4m / Enterprise Value 22.39b)
FCF Margin = 31.73% (FCF TTM 229.4m / Revenue TTM 723.0m)
Net Margin = 27.50% (Net Income TTM 198.9m / Revenue TTM 723.0m)
Gross Margin = 75.41% ((Revenue TTM 723.0m - Cost of Revenue TTM 177.8m) / Revenue TTM)
Gross Margin QoQ = 76.25% (prev 75.84%)
Tobins Q-Ratio = 15.98 (Enterprise Value 22.39b / Total Assets 1.40b)
Interest Expense / Debt = -2479 % (Interest Expense -31.9m / Debt 1.29m)
Taxrate = 21.02% (24.3m / 115.4m)
NOPAT = 131.6m (EBIT 166.6m * (1 - 21.02%))
Current Ratio = 12.78 (Total Current Assets 1.29b / Total Current Liabilities 101.0m)
Debt / Equity = 0.00 (Debt 1.29m / totalStockholderEquity, last quarter 1.27b)
Debt / EBITDA = -0.82 (Net Debt -140.4m / EBITDA 171.6m)
Debt / FCF = -0.61 (Net Debt -140.4m / FCF TTM 229.4m)
Total Stockholder Equity = 1.10b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.19% (Net Income 198.9m / Total Assets 1.40b)
RoE = 18.02% (Net Income TTM 198.9m / Total Stockholder Equity 1.10b)
RoCE = 15.08% (EBIT 166.6m / Capital Employed (Equity 1.10b + L.T.Debt 1.29m))
RoIC = 11.92% (NOPAT 131.6m / Invested Capital 1.10b)
WACC = 14.80% (E(23.53b)/V(23.53b) * Re(14.80%) + (debt cost/tax rate unavailable))
Discount Rate = 14.80% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 8.83%
[DCF Debug] Terminal Value 57.59% ; FCFE base≈174.3m ; Y1≈175.2m ; Y5≈187.7m
Fair Price DCF = 8.45 (DCF Value 1.43b / Shares Outstanding 168.9m; 5y FCF grow 0.0% → 3.0% )
EPS Correlation: 85.98 | EPS CAGR: 123.4% | SUE: 1.68 | # QB: 2
Revenue Correlation: 95.44 | Revenue CAGR: 141.7% | SUE: 3.54 | # QB: 3

Additional Sources for ALAB Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle